Published in J Pain Res on July 28, 2017
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol (1988) 60.71
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev (1999) 6.26
The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain (1983) 5.83
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain (2004) 4.72
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol (2011) 4.72
Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci (2010) 3.38
Fibromyalgia: a clinical review. JAMA (2014) 2.65
Effects of caffeine on human behavior. Food Chem Toxicol (2002) 2.32
Adenosine receptor activation and nociception. Eur J Pharmacol (1998) 1.74
Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev (2012) 1.53
Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol (1995) 1.52
Caffeine and chronic back pain. Arch Phys Med Rehabil (1997) 1.43
Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull (2011) 1.37
Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: a prospective, observational cohort study. Anesthesiology (2013) 1.37
Release of norepinephrine in the central nervous system by theophylline and caffeine. Eur J Pharmacol (1970) 1.26
The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate? Hum Brain Mapp (2009) 1.24
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. Brain (2014) 1.21
Controlling murine and rat chronic pain through A3 adenosine receptor activation. FASEB J (2012) 1.20
Caffeine as an analgesic adjuvant. JAMA (1984) 1.17
Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev (1993) 1.16
Caffeine-Not just a stimulant. Nutrition (2010) 1.11
Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther (1994) 1.06
Antinociceptive effects of novel A2B adenosine receptor antagonists. J Pharmacol Exp Ther (2003) 1.05
Pharmacological rationale for the clinical use of caffeine. Drugs (1995) 1.03
Decreased inflammatory pain due to reduced carrageenan-induced inflammation in mice lacking adenosine A3 receptors. Neuroscience (2002) 0.97
Longitudinal assessment of pain outcomes in the clinical setting: development of the "APOLO" electronic data capture system. Reg Anesth Pain Med (2012) 0.96
Characteristics of chronic pain patients who take opioids and persistently report high pain intensity. Reg Anesth Pain Med (2013) 0.93
Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport. Life Sci (1982) 0.92
Methylxanthines and pain. Handb Exp Pharmacol (2011) 0.91
Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function. J Psychopharmacol (2003) 0.90
Caffeine stimulates beta-endorphin release in blood but not in cerebrospinal fluid. Life Sci (1982) 0.89
Cigarette smoking and pain: depressive symptoms mediate smoking-related pain symptoms. Pain (2012) 0.88
Reports of chronic pain in childhood and adolescence among patients at a tertiary care pain clinic. J Pain (2013) 0.87
Effects of caffeine on central monoamine neurons. J Pharm Pharmacol (1972) 0.83
Effects of hot tea, coffee and water ingestion on physiological responses and mood: the role of caffeine, water and beverage type. Psychopharmacology (Berl) (1997) 0.82
Adenosine receptor targets for pain. Neuroscience (2015) 0.82
Validity of PROMIS physical function measured in diverse clinical samples. J Clin Epidemiol (2016) 0.81
The cognitive effects of opioids in cancer: a systematic review. Support Care Cancer (2008) 0.80
Caffeine as an adjuvant therapy to opioids in cancer pain: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage (2013) 0.80
Caffeine and chronic low back pain. Clin J Pain (1995) 0.79
Morphine--caffeine analgesic interaction in rats. Anesth Analg (1985) 0.78
Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A₁ receptors. Eur J Pharmacol (2011) 0.77
Effects of caffeine as an adjuvant to morphine in advanced cancer patients. A randomized, double-blind, placebo-controlled, crossover study. J Pain Symptom Manage (2001) 0.76
Caffeine at Moderate Doses Can Inhibit Acupuncture-Induced Analgesia in a Mouse Model of Postoperative Pain. J Caffeine Res (2013) 0.76
The effect of methylxanthines on morphine analgesia in mice and rats. Pol J Pharmacol Pharm (1989) 0.76
Potentiation of morphine analgesia by caffeine. Br J Pharmacol (1985) 0.76
A review of caffeine's effects on cognitive, physical and occupational performance. Neurosci Biobehav Rev (2016) 0.76
Tramadol and Tramadol+Caffeine Synergism in the Rat Formalin Test Are Mediated by Central Opioid and Serotonergic Mechanisms. Biomed Res Int (2015) 0.75